| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1367 | 2018 |
| Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ... The Lancet 398 (10313), 1811-1824, 2021 | 377 | 2021 |
| A CTLA‐4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism K Kotsa, PF Watson, AP Weetman Clinical endocrinology 46 (5), 551-554, 1997 | 339 | 1997 |
| The effects of a combined strength and aerobic exercise program on glucose control and insulin action in women with type 2 diabetes SP Tokmakidis, CE Zois, KA Volaklis, K Kotsa, AM Touvra European journal of applied physiology 92 (4), 437-442, 2004 | 298 | 2004 |
| Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome K Kotsa, MP Yavropoulou, O Anastasiou, JG Yovos Fertility and sterility 92 (3), 1053-1058, 2009 | 199 | 2009 |
| Vitamin D and chronic diseases: the current state of the art G Muscogiuri, B Altieri, C Annweiler, G Balercia, HB Pal, BJ Boucher, ... Archives of toxicology 91, 97-107, 2017 | 196 | 2017 |
| Combined strength and aerobic training increases transforming growth factor-β1 in patients with type 2 diabetes AM Touvra, KA Volaklis, AT Spassis, CE Zois, HT Douda, K Kotsa, ... Hormones 10, 125-130, 2011 | 165 | 2011 |
| Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke G Muscogiuri, C Annweiler, G Duval, S Karras, G Tirabassi, G Salvio, ... International journal of cardiology 230, 577-584, 2017 | 144 | 2017 |
| Vitamin D and diabetes mellitus: Causal or casual association? M Grammatiki, E Rapti, S Karras, RA Ajjan, K Kotsa Reviews in Endocrine and Metabolic Disorders 18 (2), 227-241, 2017 | 117 | 2017 |
| Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications CL Wagner, BW Hollis, K Kotsa, H Fakhoury, SN Karras Reviews in Endocrine and Metabolic Disorders 18, 307-322, 2017 | 104 | 2017 |
| Maternal vitamin D levels during pregnancy and neonatal health: evidence to date and clinical implications SN Karras, H Fakhoury, G Muscogiuri, WB Grant, JM van den Ouweland, ... Therapeutic advances in musculoskeletal disease 8 (4), 124-135, 2016 | 93 | 2016 |
| Lipoprotein profile, glycemic control and physical fitness after strength and aerobic training in post-menopausal women with type 2 diabetes ZE Christos, SP Tokmakidis, KA Volaklis, K Kotsa, AM Touvra, E Douda, ... European journal of applied physiology 106, 901-907, 2009 | 90 | 2009 |
| Vitamin D in fibromyalgia: a causative or confounding biological interplay? S Karras, E Rapti, S Matsoukas, K Kotsa Nutrients 8 (6), 343, 2016 | 76 | 2016 |
| The role of telenursing in the management of Diabetes Type 1: A randomized controlled trial K Kotsani, V Antonopoulou, A Kountouri, M Grammatiki, E Rapti, S Karras, ... International journal of nursing studies 80, 29-35, 2018 | 71 | 2018 |
| No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population KD Kotsa, PF Watson, AP Weetman Thyroid 7 (1), 31-33, 1997 | 67 | 1997 |
| VDR TaqI is associated with obesity in the Greek population Y Vasilopoulos, T Sarafidou, K Kotsa, M Papadimitriou, Y Goutzelas, ... Gene 512 (2), 237-239, 2013 | 65 | 2013 |
| Obesity, metabolic syndrome and the risk of microvascular complications in patients with diabetes mellitus N Katsiki, P Anagnostis, K Kotsa, DG Goulis, DP Mikhailidis Current pharmaceutical design 25 (18), 2051-2059, 2019 | 56 | 2019 |
| Cinin hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review MP Yavropoulou, K Kotsa, AG Psarrakou, A Papazisi, T Tranga, S Ventis, ... Hormones 9, 274-278, 2010 | 55 | 2010 |
| Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5 CAM Buse JB, Rodbard HW, Trescoli Serrano C, Luo J, Ivanyi T, Bue-Valleskey ... Diabetes Care 39 (1), 92-100, 2016 | 51 | 2016 |
| Remission as an emerging therapeutic target in type 2 diabetes in the era of new glucose-lowering agents: benefits, challenges, and treatment approaches D Vasdeki, T Koufakis, G Tsamos, L Busetto, P Zebekakis, K Kotsa Nutrients 14 (22), 4801, 2022 | 48 | 2022 |
